Efficacy and Safety of Stalevo in Subjects With Early Wearing-off Identified Using a Screening Tool WOQ-9; an Open, Non-randomised, Multinational, Multicentre 6-week Direct Switch Study in Levodopa-treated Parkinson's Disease Patients
Phase of Trial: Phase IV
Latest Information Update: 28 Apr 2015
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms SENSE
- Sponsors Orion
- 21 Jan 2008 Status changed from in progress to completed according to ClinicalTrials.gov
- 12 Oct 2007 The expected completion date for this trial is now 1 Dec 2007.
- 21 Sep 2007 Status changed from recruiting to in progress.